Malaysian state-backed Khazanah Nasional is currently pursuing talks with Turkish hospital group Acibadem in what could be a USD 500 million equity deal. The Malaysian government’s investment arm is among several buyers looking to invest in Acibadem, and direct talks are in progress with Almond Holding. Other investors like KKR and Blackstone group are also in for the purchase bid.
Acibadem (www.acibademinternational.com)
Acibadem is a publicly traded Turkey-based company founded in 1991. The group boasts 11 general-purpose hospitals, 7 medical centers and outpatient clinics and 8,500 staff physicians.
The Acibadem University was founded in 2007 and now acts as their primary medical research facility.
Two additional hospitals will be added to the portfolio shortly: Acibadem Bodrum Hospital and Acibadem Hospital, Ankara.
Acibadem’s majority stakeholder is Almond Holding (92 percent), which in turn is majority-owned by the Turkish Aydinlar family (54 percent) and the rest by Dubai-based Abraaj Capital Group.
Khazanah Nasional (www.khazanah.com.my)
Khazanah Nasional is Malaysia’s Sovereign Wealth Fund, entrusted with the country’s commercial assets. Khazanah’s wide range of portfolio companies include Apollo Hospitals, India’s largest private healthcare provider, Proton Holdings, maker of Malaysia’s first car, and Astro All Asia Networks plc.
29/09/2011
Central & Eastern Europe, Healthcare Service & Pharmaceuticals, Private Equity News, Turkey